uMotif and Xperiome Rare Disease Recruitment Collaboration


uMotif has announced its collaboration with Xperiome to bring value to both life science companies conducting clinical trials and the patients participating in them, offering an approach to patient recruitment through a community of patients and an engagement platform to drive retention.

Specifically, the partnership will leverage Xperiome’s knowledge of rare disease to build an understanding of hard-to-reach populations. Xperiome combines these insights with a specialized matching engine, to connect research-ready members to clinical and real-world study opportunities. Then, once enrolled, uMotif’s patient-engagement app will capture large volumes of ePRO, eDiary and symptom data in real-time throughout the duration of a clinical study. The uMotif app empowers patients to manage and collect their own data.

Read more about uMotif and Xperiome’s partnership

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.